报价延迟最少15分钟:2025/08/27 03:28 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.27 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.32/-0.58
|
|
企业价值
23.40M
|
| 资产负债 |
|
每股账面净值
0.00
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
48.67M
|
|
每股收益
3.32
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/08/27 03:28 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim. |
